dc.contributor.advisor | Jamiruddin, Mohd. Raeed | |
dc.contributor.author | Tarafder, Ayndrila | |
dc.date.accessioned | 2024-01-25T06:41:30Z | |
dc.date.available | 2024-01-25T06:41:30Z | |
dc.date.copyright | 2023 | |
dc.date.issued | 2023-07 | |
dc.identifier.other | ID 18346076 | |
dc.identifier.uri | http://hdl.handle.net/10361/22198 | |
dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. | en_US |
dc.description | Cataloged from PDF version of thesis. | |
dc.description | Includes bibliographical references (pages 29-35). | |
dc.description.abstract | This dissertation focuses on the treatment regiments of urinary bladder adenocarcinoma.Specifically, we assess the effects of various drug-based therapy regimens on the survival and response rates of individuals with this cancer and present a comparative analysis among them. This dissertation addresses the analysis by reviewing existing studies and related clinical trials from the literature. In general, this dissertation can be divided into three independent but interrelated sections. First, we present epidemiology, classification, and histological features of common urinary bladder adenocarcinomas. Second, we review existing treatment regimens by dividing them as non-surgical, surgical, and other treatment options. Further, we group the drug combinations corresponding to non-surgical methods as either cisplatin-based or not. Finally, we develop a comparative analysis among different treatment plans. Based on the comparative analysis, we show that the efficacy of cisplatin-based drugs is better than other drug-based prescriptions for treating urinary bladder adenocarcinoma. | en_US |
dc.description.statementofresponsibility | Ayndrila Tarafder | |
dc.format.extent | 35 pages | |
dc.language.iso | en | en_US |
dc.publisher | Brac University | en_US |
dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
dc.subject | Bladder | en_US |
dc.subject | Adenocarcinoma | en_US |
dc.subject | Cisplatin | en_US |
dc.subject | Treatment | en_US |
dc.subject.lcsh | Bladder--Diseases | |
dc.title | Treatment regimens of urinary bladder adenocarcinoma | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | School of Pharmacy, Brac University | |
dc.description.degree | B. Pharmacy | |